Novel assay method for mitoxantrone in plasma, and its application in cancer patients
- 31 December 1990
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 532 (2) , 337-350
- https://doi.org/10.1016/s0378-4347(00)83783-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.Journal of Clinical Oncology, 1987
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Radioimmunoassay for mitoxantrone, a new antitumor agentInvestigational New Drugs, 1985
- Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantroneJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- High-performance liquid chromatography of cancer chemotherapeutic agents: bis(substituted aminoalkylamino)anthraquinonesJournal of Chromatography A, 1980
- An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in SerumJournal of Liquid Chromatography, 1980